Cargando…
Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin
BACKGROUND: Translationally controlled tumour protein TCTP is an anti-apoptotic protein frequently overexpressed in cancers, where high levels are often associated with poor patient outcome. TCTP may be involved in protecting cancer cells against the cytotoxic action of anti-cancer drugs. Here we st...
Autores principales: | Bommer, Ulrich-Axel, Vine, Kara L., Puri, Prianka, Engel, Martin, Belfiore, Lisa, Fildes, Karen, Batterham, Marijka, Lochhead, Alistair, Aghmesheh, Morteza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286767/ https://www.ncbi.nlm.nih.gov/pubmed/28143584 http://dx.doi.org/10.1186/s12964-017-0164-3 |
Ejemplares similares
-
Antichemosensitizing effect of resveratrol in cotreatment with oxaliplatin in HCT116 colon cancer cell
por: Park, Dong-Guk
Publicado: (2014) -
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
por: Sohn, Won Jun, et al.
Publicado: (2010) -
Dysregulation of TCTP in Biological Processes and Diseases
por: Bommer, Ulrich-Axel, et al.
Publicado: (2020) -
Role of TCTP in Cell Biological and Disease Processes
por: Bommer, Ulrich-Axel, et al.
Publicado: (2021) -
Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells
por: Wang, Mengge, et al.
Publicado: (2022)